article Open AccessTop 1% cited

MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy

Cancer · 2014 · Vol. 120(10) · pp. 1453–1461

Rajesh V. Lalla✉(University of Connecticut)Joanne M. Bowen(University of Adelaide)Andrei Barasch(Winthrop-University Hospital)Linda S. Elting(The University of Texas MD Anderson Cancer Center)Joel B. Epstein(City Of Hope National Medical Center)Dorothy Keefe(University of Adelaide)Deborah B. McGuire(Virginia Commonwealth University)César A. Migliorati(University of Tennessee Health Science Center)Ourania Nicolatou‐Galitis(National and Kapodistrian University of Athens)Douglas E. Peterson(University of Connecticut)Judith E. Raber‐Durlacher(Academic Medical Center)Stephen T. Sonis(Brigham and Women's Hospital)Elad Sharon(University of Rochester)

View via DOI Full-text PDF

Abstract

The updated MASCC/ISOO Clinical Practice Guidelines for mucositis will help clinicians provide evidence-based management of mucositis secondary to cancer therapy.

Oral health in cancer treatment Head and Neck Cancer Studies Cancer Diagnosis and TreatmentMucositisMedicineGuidelineCancerIntensive care medicineCancer therapySystematic reviewPsychological interventionClinical PracticeMEDLINE

MeSH terms

AnalgesicsAnti-Infective AgentsAnti-Inflammatory AgentsAnti-Ulcer AgentsAntineoplastic AgentsEsophagitisAmifostineHumansHyperbaric OxygenationNeoplasmsOral HygienePhototherapyProctitisRadiation-Protective AgentsRadiotherapy

Citations

1,079

FWCI

65.91

field-weighted impact

References

Percentile

100%

vs. same field & year

Citations per year

Cited by

Photobiomodulation—Underlying Mechanism and Clinical Applications